• Overview
  • Eligibility
  • More info
  • Locations

A Cross-sectional, Prospective, Observational Study to Evaluate Blood Flow Characteristics in Glaucoma Patients Using Optical Coherence Tomography Based Angiography (OCT-A). (NCT02757677)

The investigators aim to evaluate the efficacy of the new Optical Coherence Tomography based Angiography (OCT-A) softwares in the diagnosis and management of glaucoma.
  • Device: Optical Coherence Tomography based Angiography
    A contrast-free, noninvasive technology to identify blood vessels in the eye
    Ages eligible for Study
    18 Years and older
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    No
    Inclusion Criteria:
    • Diagnosis of open angle glaucoma (OAG) including pseudo-exfoliative and pigmentary glaucoma.
    • Documented glaucomatous visual field damage (in the previous 12 months with mean defect (MD) > 2.0 dB)
    • Structural and/or functional glaucomatous damage
    • Have given written informed consent, prior to any investigational procedures
    Exclusion Criteria:
    • Patients with allergy to corneal anesthetic
    • Patients not able to understand the character and individual consequences of the investigation
    • Participation in other clinical research within the last 4 weeks
    • Other diseases that may cause visual field loss or optic disc abnormalities
    • Refractive error of > +3.00D or < -7.00D

    1 locations

    Switzerland (1)
    • Glaucoma center, Montchoisi clinic
      recruiting
      Lausanne, Switzerland, 1006
    Status:
    unknown
    Type:
    Observational
    Phase:
    -
    Start:
    30 November, 2015
    Updated:
    26 April, 2016
    Participants:
    500
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!